{
    "clinical_study": {
        "@rank": "41986", 
        "arm_group": [
            {
                "arm_group_label": "Cristalloid", 
                "arm_group_type": "Active Comparator", 
                "description": "group cristalloid (ringer lactate)"
            }, 
            {
                "arm_group_label": "colloids", 
                "arm_group_type": "Active Comparator", 
                "description": "colloid: cristalloid in according to cardiac output"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators hypothesize that large doses of fluids used during intraoperative could\n      affect lung parenchyma structure and, consequently, gas exchange and respiratory mechanics.\n      The purpose of this study  is to evaluate fluids effects on oxygenation, respiratory\n      mechanics, by using two different solutions: crystalloid or colloid."
        }, 
        "brief_title": "Evaluation of the Effects of Fluid Therapy on Respiratory Mechanics", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Mechanical Ventilation Complication", 
            "Actual Impaired Fluid Volume"
        ], 
        "detailed_description": {
            "textblock": "Inclusion Criteria:\n\n        -  patients undergoing elective abdominal, thoracic, vascular surgery\n\n        -  minimum age 18 years\n\n        -  informed consent\n\n      Exclusion Criteria:\n\n        -  patients with severe cardiomyopathy or severe heart failure\n\n        -  history of coagulation disorders\n\n        -  patients with severe cardiovascular or respiratory disorders\n\n        -  renal insufficiency\n\n      Respiratory mechanic parameters (i.e., inspiratory peak pressure, plateau pressure, total\n      airway resistance, and static compliance) are obtained .Blood samples are drawn\n      simultaneously from the arterial catheters for gas analysis. Data were collected after\n      induction of anesthesia (T0) after 1 h (T1), 2 h (T2),  3 h (T3) and at  the end of surgery.\n\n      Primary outcome: evaluate the  fluids effects on oxygenation, respiratory mechanics\n\n      Secondary outcome: Incidence of surgery related complications"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients undergoing elective abdominal, thoracic, vascular surgery\n\n          -  minimum age 18 years\n\n          -  informed consent\n\n        Exclusion Criteria:\n\n          -  patients with severe cardiomyopathy or severe heart failure\n\n          -  history of coagulation disorders\n\n          -  patients with severe cardiovascular or respiratory disorders\n\n          -  renal insufficiency\n\n          -  severe liver diseases"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02071524", 
            "org_study_id": "22012014"
        }, 
        "intervention": [
            {
                "arm_group_label": "colloids", 
                "description": "Group Colloid: cristalloid 1:2 (gelofusine: ringer lactate)", 
                "intervention_name": "Group Colloid", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Cristalloid", 
                "description": "Only Ringer Lactate administration", 
                "intervention_name": "Cristalloid administration", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 21, 2014", 
        "location": {
            "contact": {
                "email": "vlc@unife.it", 
                "last_name": "Carlo A Volta, professor", 
                "phone": "+390532206570"
            }, 
            "facility": {
                "address": {
                    "city": "Ferrara", 
                    "country": "Italy", 
                    "zip": "44121"
                }, 
                "name": "University of Ferrara"
            }, 
            "investigator": {
                "last_name": "Savino Spadaro, Researcher", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "spdsvn@unife.it", 
            "last_name": "Savino Spadaro, researcher", 
            "phone": "+390532206570"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Lung compliance (l/cmH20), Airaway resistance (cmH2O/L/sec) and PaO2 will be measured", 
            "measure": "effects on oxygenation, respiratory mechanics", 
            "safety_issue": "Yes", 
            "time_frame": "every 30 minutes till the end of surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02071524"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universit\u00e0 degli Studi di Ferrara", 
            "investigator_full_name": "Savino Spadaro", 
            "investigator_title": "Researcher", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Complications like acute respiratory failure, pneumonia and ARDS will be recorded", 
            "measure": "Incidence of respiratory complications", 
            "safety_issue": "Yes", 
            "time_frame": "28 days"
        }, 
        "source": "Universit\u00e0 degli Studi di Ferrara", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universit\u00e0 degli Studi di Ferrara", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}